ALUMINA CATALYST: SYNTHESIS OF NOVEL QUINAZOLINE DERIVATIVES AND THEIR SOLUBILITY INCREASES THROUGH INCLUSION WITH β-CYCLODEXTRIN
Objective: To synthesis a novel methodology of bioactive quinazoline derivatives under greener process to an excellent yields and increases their solubility via inclusion with β-cyclodextrin (CD).
Methods: Derivatives of quinazoline compounds were prepared by the mixture of 3-amino-2-phenylquinazolin-4(3H)-one, derived from 2-phenyl-4H-benzo[1,3]oxazin-4-one by refluxing with hydrazine, substituted aromatic aldehyde and alumina intimately in an agate mortar and pestle under solvent-free condition. Using various techniques for preparing inclusion complexes, kneaded method is the best method for encapsulation in host-guest complex chemistry. All compounds including inclusion complexes were characterised by spectral methods.
Results: Synthesized a series of novel quinazoline compounds under a very easier greener process with a commercially available reagent. However, their low bioavailability, due to low absorption and solubility, can limit their potential applications. CD was used to resolve this solubility problem. CD can easily accommodated the guest molecules to encapsulate inside its cavity due to interior the hydrophobic nature with a hydrophilic exterior part to form thermodynamically more stable molecular microcapsules, commonly name as host-guest complexes or inclusion complexes. In this sense, CD was utilized to enhance not only the solubility and bioavailability of these quinazoline compounds but also their antibacterial capacity. The formation of inclusion complex was thus confirmed by ultraviolet-visible spectroscopy (UV-VIS), Fourier Transform Infrared Spectrometry (FT-IR), differential scanning calorimetry (DSC) and solubility study technique.
Conclusion: Here we have successfully unfolded an eco-friendly methodology for the synthesis of derivatives of quinazoline and increased their solubility via host-guest inclusion technique. From the spectral analysis, it was concluded that the quinazoline compound is fully encapsulated inside the cavity of the CD.
2. Vijayakumar B, Prasanthi P, Muni Teja K. Quinazoline derivatives and pharmacological activities, a review. IJMCA 2013;3:10-21.
3. Coatney GR, Cooper WC, Culwell WB, White WC, Imboden CA Jr. Studies in human malaria. XXV. Trial of febrifugine, an alkaloid obtained from dichroa febri fuga Lour, against the chesson strain of plasmodium vivax. J Natl Malar Soc 1950;9:183?6.
4. Fishman M, Cruckshank PA. Febrifugine antimalarial agents. J Med Chem 1970;13:155-6.
5. Zhu S, Chandrashekar G, Meng L. Febrifugine analogue compounds: synthesis and antimalarial evaluation Bioorg Med Chem 2012;20:927-32.
6. Van Horn KS, Burda WN, Fleeman R. Antibacterial activity of a series of N2,N4-disubstituted quinazoline-2,4-diamines. J Med Chem 2014;57:3075-93.
7. Lam T, Hilgers MT, Cunningham ML. Structure-based design of new dihydrofolate reductase antibacterial agents: 7-(Benzimidazol-1-yl)-2,4-diaminoquinazolines. J Med Chem 2014;57:651-68.
8. Marzaro G, Guiotto A, Chilin A. Quinazoline derivatives as potential anticancer agents: a patent review (2007–2010). Expert Opin Ther Pat 2012;22:223-52.
9. Bilbro J, Mart M, Kyprianou N. Therapeutic value of quinazoline-based compounds in prostate cancer. Anticancer Res 2013;33:695-700.
10. Honkanen E, Pippuri A, Kairisalo P. Synthesis and anti-hypertensive activity of some new quinazoline derivatives. J Med Chem 1983;26:1433-8.
11. Singh B, Sharma RA. Anti-inflammatory and antimicrobial properties of pyrroloquinazoline alkaloids from Adhatoda vasica nees. Phytomedicine 2013;20:441-5.
12. Zhu S, Chandrashekar G, Meng L. Febrifugine analogue compounds: synthesis and antimalarial evaluation. Bioorg Med Chem 2012;20:927-32.
13. Nanjwade BK, Derkar GK, Bechra HM, Nanjwade VK, Manvi FV. Design and characterization of nanocrystals of lovastatin for solubility and dissolution enhancement. Nanomed Nanotechnol 2011;2:107.
14. Nanda AK, Ganguli S, Chakraborty R. Antibacterial activity of some 3-(Arylideneamino)-2-phenylquinazoline-4(3H)-ones: synthesis and preliminary QSAR studies. Molecules 2007; 12:2413-26.
15. Shirke SH, Shewale SB, Kulkarni AS, Aloorkar NH. Solid dispersion: a novel aapproach for poorly water-soluble drugs. Int J Curr Pharm Res 2015;7:1-8.
16. Singh M, Sharma R, Banerjee UC. Biotechnological applications of cyclodextrins. Biotechnol Adv 2002;20:341-59.
17. Ogoshi T, Chujo Y. Synthesis of organic-inorganic polymer hybrids by means of host-guest interaction utilizing cyclodextrin. Macromolecules 2003;36:654-60.
18. Wulff M, Alden M, Tegenfeldt J. Solid-state NMR investigation of indomethacin?cyclodextrin complexes in PEG 6000 carrier. Bioconjugate Chem 2002;13:240-8.
19. Asanuma HA, Hishiya T, Komiyama M. Tailor-made receptors by molecular imprinting. Adv Mater 2000;12:1019-30.
20. Bassani VL, Krieger D, Duchene D, Woue D. Enhanced water-solubility of albendazole by hydroxypropyl-b-cyclodextrin complexation. J Incl Phenom Macrocycl Chem 1996;25:149–52.
21. Buvari Barcza A, Barcza L. Changes in the solubility of bcyclodextrin on complex formation: guest enforced solubility of b-cyclodextrin inclusion complexes. J Incl Phenom Macrocycl Chem 2000;36:355–70.
22. Nasongkla N, Wiedmann AF, Bruening A, Beman M, Ray D, Bornmann WG, et al. Enhancement of solubility and bioavailability of b-lapachone using cyclodextrin inclusion complexes. Pharm Res 2003;20:1626–33.
23. Ammar HO, Salama HA, Gharab M, Mahmoud AA. An implication of inclusion complexation of glimepiride in cyclodextrin–polymer systems on its dissolution, stability, and therapeutic efficacy. Int J Pharm 2006;320:53-7.
24. Loftsson T, Brewster ME. Pharmaceutical applications of cyclodextrins. Drug solubilization and stabilization. J Pharm Sci 1996;85:1017-25.
25. Ghodkea DS, Nakhatb PD, Yeole PG, Naikwade NS, Magduma CS, Shaha RR. Preparation and characterization of domperidone inclusion complexes with cyclodextrin: Influence of preparation method. Iran J Pharm Res 2009;8:145-51.
26. Karathanos VT, Mourtzinos I, Yannakopoulou K, Andrikopoulos NK. Study of the solubility, antioxidant activity, and structure of inclusion complex of vanillin with ?-cyclodextrin. Food Chem 2007;10:652–8.
27. Shankarguru P, Ramya DD, Vedha Hari BN. Effect of water content in the kneading method of solid dispersion technique for solubility enhancement. Int J Appl Pharm 2017;9:14-21.
28. Al-Marzouqi AH, Solieman A, Shehadi I, Adem A. Influence of the preparation method on the physicochemical properties of econazole ?-cyclodextrin complexes. J Incl Phenom Macrocycl Chem 2008;60:85–93.
29. Doile MM, Fortunato KA, Schmücker IC, Schucko SK, Silva MAS, Rodrigues PO. Physicochemical properties and dissolution studies of dexamethasone acetate ?-cyclodextrin inclusion complexes produced by different methods. AAPS PharmSciTech 2008;9:314-21.
30. Pralhad T, Rajendrakumar K. Study of freeze-dried quercetin–cyclodextrin binary systems by DSC, FT-IR, X-ray diffraction and SEM analysis. J Pharm Biomed Anal 2004;34:333–9.
31. Kurmi R, Mishra DK, Jain DK. Solid dispersion: a novel means of solubility enhancement. J Crit Rev 2016;3:1-8.
32. Pradhan K, Tiwary BK, Hossain M, Chakraborty R, Nanda AK. A mechanistic study of carbonyl activation under solvent-free conditions: evidence drawn from the synthesis of imidazoles. RSC Adv 2016;6:10743-9.
33. Hossain M, Pradhan K, Nanda AK. An expeditious synthetic protocol for chlorination of imidazole N-oxide: synthesis of 2-chloroimidazoles. Tetrahedron Lett 2017;58:3772–6.
34. Chen J, Qin X, Zhong S, Chen S, Su W, Liu Y. Characterization of curcumin/cyclodextrin polymer inclusion complex and investigation on its antioxidant and antiproliferative activities. Molecules 2018;23:1179.
35. Raza A, Sun H, Bano S, Zhao Y, Xu X, Tang J. Preparation, characterization, and in vitro anti-inflammatory evaluation of novel water-soluble kamebakaurin/hydroxypropyl-?-cyclodextrin inclusion complex. J Molecular Structure 2016;1130:319-26.
36. Wei Y, Zhang J, Zhou Yan, Bei W, Li Y, Yuan Q, et al. Characterization of glabridin/hydroxypropyl-?-cyclodextrin inclusion complex with robust solubility and enhanced bioactivity. Carbohydrate Polymers 2016;159. Doi.org/ 10.1016/j.carbpol.2016.11.09.
37. Raghad Al-N, Hind El-Z. Enhancement of candesartan cilexetil dissolution rate by using different methods. Asian J Pharm Clin Res 2015;8:320-6.
38. Chen W, Yang LJ, Ma SX. Crassicauline ?/?-cyclodextrin host-guest system: Preparation, characterization, inclusion mode, solubilization, and stability. Carbohyd Polym 2011;84:1321–8.
39. Liu L, Zhu S. Preparation and characterization of inclusion complexes of prazosin hydrochloride with ?-cyclodextrin and hydroxypropyl-?-cyclodextrin. J Pharmaceut Biomed 2006; 40:122–7.
40. Mendhe AA, Kharwade RS, Mahajan UN. Dissolution enhancement of poorly water-soluble drug by cyclodextrins inclusion complexation. Int J Appl Pharm 2016;8:60-5.
41. Lizy RS, Prema KJ. Inclusion studies on ?-cyclodextrin complexes of glipizide and gliclazide with an effect of PH. Asian J Pharm Clin Res 2017;10:273-80.
42. Sulaiman HT, Kassab HJ. Preparation and characterization of econazole nitrate inclusion complex for an ocular delivery system. Int J Appl Pharm 2018;10:175-81.